Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-806-7 | CAS number: 88-17-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 10 may 2006 to 27 march 2007
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was performed according to the standardised method (OECD guideline 429), well described, but not GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- no
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- α,α,α-trifluoro-o-toluidine
- EC Number:
- 201-806-7
- EC Name:
- α,α,α-trifluoro-o-toluidine
- Cas Number:
- 88-17-5
- Molecular formula:
- C7H6F3N
- IUPAC Name:
- 2-(trifluoromethyl)aniline
- Reference substance name:
- alpha,alpha,alpha-trifluoro-o-toluidine
- IUPAC Name:
- alpha,alpha,alpha-trifluoro-o-toluidine
- Details on test material:
- Name: orthotrifluoromethylaniline pure
Synonym: 2-Aminobenzotrifluoride pure grade
Batch number at receipt: CHH0K001
Batch number on the analytical certificate: CHHDKA001
Both batch numbers refer to the same product.
CAS: 88-17-5
Appearance: colorless liquid
Date of receipt: 120 june 2006
Storage conditions: at room temperature
Constituent 1
Constituent 2
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Age at study initiation: 8 to 12 weeks old
- Weight at study initiation: 18 to 25 g and within a range of +/- 20% of the mean body weight
- Housing: the animals will be individually housed in disposable crystal polystyrene cages (22.0 cm x 8.5 cm x 8.0 cm).
- Diet: All animals will have free access to SSNIFF R/M-H pelleted diet (SSNIFF Spezialdiäten GmbH, Soest, Germany)
- Water: tap water (filtered using a 0.22 micron filter) contained in bottles
- Acclimation period: at least 5 days before the begginning of the study.
ENVIRONMENTAL CONDITIONS
- temperature : 22 ± 2°C,
- relative humidity: 30 to 70%,
- light/dark cycle: 12 h/12 h,
- ventilation: approximately 12 cycles/hour of filtered, non-recycled air.
IN-LIFE DATES: from 26 december 2006 to 09 january 2007
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 25, 50 and 100%
- No. of animals per dose:
- 4
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: test item was freely soluble in the vehicle
- Irritation: non irritant
- Lymph node proliferation response: no
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- animals were assigned to the treatment groups by hand procedure.
Identification: individually by a number on the tail using an indelible marker.
- Criteria used to consider a positive response: The test item should be regarded as a skin sensitizer when the SI for a dose group is >=3. Other relevant criteria such as cellularity, radioactivity levels and ear thickness will be also taken into account to evaluate the data. When appropriate, the EC3 value (theoretical concentration resulting in a SI value of 3) will be determined by linear interpolation of points on the dose-response curve, immediately above and below the 3-fold threshold.
The equation used for calculation of EC3 will be: EC3 = c + [(3 - d)/(b - d)] x (a - c) Where a = the lowest concentration giving stimulation > 3;
b = the actual stimulation index caused by a;
c = the highest concentration failing to produce a stimulation index of 3;
and d = the actual stimulation index caused by c.
TREATMENT PREPARATION AND ADMINISTRATION:
The animals were allocated to four groups:three treated groups (4 animals each) with the test item at concentrations of 25, 50 and 100% and one negative control group of four animals receiving the vehicle. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: SI were 1.58, 3.32 and 4.74 at 25, 50 and 100% respectively.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Control group: 54.64 25%: 86.33 50%: 181.61 100%: 258.9
Any other information on results incl. tables
A significant lymphoproliferation was noted at concentrations of 50 and 100%.
In the absence of local irritation, the significant lymphoproliferative responses observed at the concentration of
50 and 100% were attributed to delayed contact hypersensitivity.
The EC3 value for the test item ORTHOTRIFLUOROMETHYLANILINE Pure is equal to 45%.
See following table:
Groups |
1 |
2 |
3 |
4 |
Concentrations (%) |
0 (Acetone/olive oil (4/1)) |
25 |
50 |
100 |
Cell count viable |
77 |
62 |
126 |
159 |
Cell count dead |
23 |
4 |
36 |
6 |
Viability (%) |
77 |
93.94 |
77.78 |
96.36 |
Amount of cells (x106cells) |
7.70 |
6.20 |
12.6 |
15.9 |
Cellularity index |
|
0.81 |
1.64 |
2.06 |
Number of nodes per group |
8 |
8 |
8 |
8 |
Disintegrations per min per gp (dpm) |
437.12 |
690.67 |
1452.84 |
2071.23 |
Disintegrations per min per node (dpm) |
54.64 |
86.33 |
181.61 |
258.9 |
stimulation index (SI) |
|
1.58 |
3.32 |
4.74 |
Increase in ear thickness (% between day 1 and day 6) |
2.91 |
-.98 |
-1.98 |
2 |
EC3 value |
|
45% |
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Orthotrifluoromethylaniline is sensitizing according to the CLP 1272/2008/EC criteria.
- Executive summary:
In a dermal sensitization study (31700 TSS, CIT) with orthotrifluoromethylaniline in acetone/olive oil (4/1), young adults CBA/J female mice (4 per group), were tested using the method of LLNA.
The test item was freely soluble in the first recommended vehicle, acetone/olive oil (4/1, v/v). A solution was obtained whatever the proportion. Consequently, the concentrations selected for the preliminary test were 50 and 100%. Since the test item was non-irritant in the preliminary test, the highest concentration retained for the main test was the maximal practicable concentration (100%).
No mortality and no clinical signs were observed during the study.
No cutaneous reactions and no noteworthy increase in ear thickness were observed in the animals of the treated groups.
A significant lymphoproliferation was noted at concentrations of 50 and 100%. In the absence of local irritation, the significant lymphoproliferative responses observed at the concentration of 50 and 100% were attributed to delayed contact hypersensitivity.
The EC3 value for the test item ORTHOTRIFLUOROMETHYLANILINE Pure is equal to 45%.
Under the experimental conditions, the test item ORTHOTRIFLUOROMETHYLANILINE Pure induced delayed contact hypersensitivity in the murine local Lymph Node Assay. According to the EC3 value obtained in this experiment, the test item ORTHOTRIFLUOROMETHYLANILINE Pure should be considered as a weak sensitizer, and classified as sensitizing according to the CLP 1272/2008/EC criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.